Introduction
The proto-oncogene c-kit encodes a receptor tyrosine kinase (RTK), c-Kit (Qiu et al., 1988; Ullrich and Schlessinger, 1990; Yarden et al., 1987) . The ligand for c-Kit is stem cell factor (SCF), also known as kit ligand, mast cell growth factor, or steel factor (Flanagan and Leder, 1990; Huang et al., 1990; Williams et al., 1990; Zsebo et al., 1990) . Binding of SCF to c-Kit promotes dimerization and phosphorylation of the receptor at critical tyrosine residues. The phosphorylated receptor then binds a variety of intracellular signaling molecules leading to a diverse number of cellular responses (Linnekin, 1999; Ullrich and Schlessinger, 1990) .
Activating mutations in the kinase domain of c-kit at codon 816 (Asp 816 ) in human and 814 (Asp 814 ) in mouse, have been identi®ed in hematopoietic cell lines (Furitsu et al., 1993; Tsujimura et al., 1994) . These mutations promote receptor autophosphorylation without the requirement of receptor-ligand interaction. In murine experimental systems, mutant c-Kit can convert cytokine dependent cell lines to cytokine independence and induce tumorigenicity (Ferrao et al., 1997; Hashimoto et al., 1996; Kitayama et al., 1995; Leslie et al., 1998) . Asp 816 mutations of c-kit have also been identi®ed in some malignancies, including acute myeloid leukemia (AML) Beghini et al., 2000; Ning et al., 2001a) , mastocytosis (Longley et al., 1999; Nagata et al., 1995) and germ cell tumors (Tian et al., 1999) . The downstream signal transduction pathways that aect the cellular changes mediated by Asp 816(human)/814(mouse) mutations of c-kit are important to de®ne as they may provide critical therapeutic targets.
STAT (Signal Transducer and Activator of Transcription) proteins are latent transcription factors that are promptly activated by tyrosine phosphorylation upon stimulation of surface receptors by extracellular ligands. Tyrosine phosphorylation allows the dimerization of individual STAT molecules via their SH2 (src homology 2) domains. Activated STATs subsequently translocate to the nucleus and bind speci®c DNA elements, leading to transcriptional activation (Darnell, 1997) . STAT signaling is involved in control of diverse biological processes regulated by extracellular ligands, including cell proliferation, dierentiation, development and survival (Bromberg and Darnell, 2000) . Increasing evidence has also demonstrated an important role for STATs in oncogenesis. For example, STAT3 and STAT5 have been found to be activated by certain oncogenes and required for cellular transformation (Bromberg et al., 1998; de Groot et al., 1999; Turkson et al., 1998) . Constitutive activation of STAT proteins is commonly observed in a wide variety of malignancies (Bowman et al., 2000) .
We have previously identi®ed Asp 816 mutations of ckit (D816H and D816N) from AML cells (Ning et al., 2001a) that confer the constitutive activation of STAT3. Further studies demonstrated that inhibition of STAT3 activation blocks mutant c-Kit mediated cytokine-independent survival and proliferation in these cells (Ning et al., 2001b) . In the current report, we show that STAT3 activation is required for mutant c-Kit mediated anchorage-independent growth and tumorigenicity.
Results
D816H mutant c-Kit promotes anchorage-independent growth of 293 cells 293 cells were transfected with either wild type or D816H mutant c-kit. Stably transfected cells and the subsequently isolated clones were determined for the expression of surface c-Kit by¯ow cytometry analysis. While both wild type and mutant c-kit transfected cells expressed the c-Kit receptor as determined on an uncloned population (Figure 1a) or by representative clones (Figure 1b) , signi®cantly less c-Kit surface expression was observed on cells transfected with D816H mutant c-kit than on cells transfected with wild type c-kit. The dierent levels of c-Kit expression between wild type and mutant c-kit transfected cells have also been observed by others (Furitsu et al., 1993; Kitayama et al., 1995; Moriyama et al., 1996; Tsujimura et al., 1994) , and they are likely due to the dierential rate of receptor degradation between the wild type and mutant c-Kit receptor .
To determine the transforming ability of mutant cKit, 293 cells transduced with either wild type or D816H mutant c-Kit were analysed by assays of anchorage-independent growth, one of the hallmarks of the tumorigenic states (Freedman and Shin, 1974) . Although 293 cells express the E1A gene derived from adenovirus 5 (Graham et al., 1977) , they rarely form tumors in nude mice when injected in lower number of cells (Arrick et al., 1992) . When seeded in lower numbers (less than 100 cells per well in 12-well culture plates), the parental 293 cells have a relatively low background of colony formation in assays for anchorage-independent growth, which is quite comparable to that of NIH3T3 cells (data not shown). Various numbers of 293 cells transfected with either wild type or D816H mutant c-kit cDNA constructs were seeded and cultured in soft agar for 14 days before colony numbers were counted. Despite lower levels of c-Kit expression, cells transfected with D816H mutant c-kit gave rise to signi®cantly greater number of colonies (®ve times more in average) than cells transfected with wild type c-kit (Figure 2a) . No signi®cant dierence in colony size was observed in various groups of cells tested above (data not shown).
To determine whether SCF stimulation could aect the anchorage independent growth, clones of 293 cells transfected with either wild type or D816H mutant ckit were cultured in soft agar with or without addition of SCF for 14 days. As shown in Figure 2b , although colony numbers of wild type c-kit-transfected cells were increased when they were treated with SCF (about 2.5 times increase over the untreated cells), they still formed signi®cantly less colonies compared with D816H mutant c-kit-transfected cells in the absence of SCF stimulation ( Figure 2b ). As expected, because colony formation by D816H mutant c-kit-transfected Suppression of STAT3 activation inhibits anchorageindependent growth of 293 cells transfected with D816H mutant c-kit
Our previous experiments have shown that constitutive activation of STAT3 and STAT1 is associated with Asp 816 mutant c-Kit in leukemia cells, and that STAT3 activation is required for mutant c-Kit induced cytokine-independent survival in these cells (Ning et al., 2001b) . To determine STAT3 activation in 293 cells expressing mutant c-Kit, cells stably transfected with either wild type or D816H mutant c-kit, as well as the empty vector, were analysed by Western blotting. Consistent with¯ow cytometry analysis, mutant c-kit-transfected 293 cells expressed signi®-cantly less c-Kit compared to wild-type c-kit-transfected cells (about eight times less determined by densitometry, Figure 3a 
STAT3 activation is able to reconstitute anchorageindependent growth of 293 cells induced by D816H mutant c-Kit
To further investigate the role of STAT3 activation in the transformation of 293 cells, cDNA plasmids encoding either FLAG-tagged wild type STAT3 or constitutively activated STAT3, STAT3-C (Bromberg et al., 1999) were transfected into the parental 293 cells. Western blotting showed the expression of exogenous FLAG-tagged STAT3 in individual clones (Figure 5a ). However, only cellular extracts from STAT3-C transfected clones demonstrated binding activity (Figure 5b , lane 4 and 5), which was greater than the DNA binding activity of the STAT3/STAT3 homodimers in kit-DH2 clone (Figure 5b, lane 10) . The DNA binding protein in STAT3-C-transfected clones was con®rmed to be STAT3-C based on the observation that the protein-DNA complexes could be super-shifted with anti-FLAG antibody (Figure 5b , lanes 6 and 7) and were signi®cantly diminished with anti-STAT3 antibody (Figure 5b, lanes 8 and 9) . Assays for anchorageindependent growth demonstrated that the two clones expressing STAT3-C formed signi®cantly more colonies than did the clone expressing the wild type STAT3 (Figure 5c ), indicating that activated STAT3 by itself is able to promote anchorage independent growth of 293 cells.
Tumor formation in NOD/SCID mice
Dierences in tumor formation of cloned 293 cells transfected with dierent c-kit and STAT cDNAs were determined in NOD/SCID mice. Clones that demonstrated signi®cant dierences in colony formation in soft agar assays were subcutaneously injected into the same mice at dierent positions along the back of the animals. 293 cells transfected with the empty vector did not show any tumor formation in NOD/SCID mice injected with 4610 5 cells over the course of 4 weeks (Table 1) . While cells transfected with wild type c-kit (clone kit-WT1) gave rise to the formation of small sized tumors in four out of six mice, all six mice injected with cells transfected with D816H mutant c-kit (clone kit-DH2) showed large tumors. Of note, the average size of tumors formed by kit-DH2 clone was nearly 10 times larger than tumors formed by kit-WT1 clone (Table 1) . However, when cells from kit-DH2 clone were transformed with dominant negative STAT3 (kitDH/ST3-YF3), the size of tumors was signi®cantly reduced. In contrast, kit-DH2 cells transfected with wild type STAT3 (kitDH/ST3-WT2) did not show a marked dierence in tumor size when compared to cells before the transfection. Consistent with assays for anchorage-independent growth, parental 293 cells transfected with constitutively activated STAT3 (ST3-C3) formed medium-sized tumors in all six mice, whereas only one small tumor was formed from cells transfected with wild type STAT3 (ST3-WT1, Table 1 ).
Discussion
Mutations at codon 816 of c-kit have been identi®ed in various malignancies, including those of hematopoietic origins such as AML Beghini et al., 2000; Ning et al., 2001a) and mastocytosis (Longley et al., 1996; Nagata et al., 1995) and solid tumor derived from germ cells (Tian et al., 1999) . Cytokineindependent survival and tumorigenicity are frequently observed phenotypic changes that have been reported to be a result of both murine (codon 814) Kitayama et al., 1995; Leslie et al., 1998; Piao and Bernstein, 1996) and human (codon 816) activating mutations of c-kit (Ning et al., 2001a) . The 293 cell line was established by transduction of human embryonic kidney cells with the adenovirus 5 DNA (Graham et al., 1977) and has been used as a model for studying signal transduction and oncogenesis, including some observations of the biological properties of Asp 816(human)/814(mouse) mutant c-Kit (Furitsu et al., 1993; Kanakura et al., 1994; Moriyama et al., 1996; Tsujimura et al., 1994 Tsujimura et al., , 1995 Yajima et al., 1998) . Furthermore, this cell line has been shown in nude mice to rarely form tumors when injected in low cell numbers (6610 5 ) and to give rise to small-sized tumors when injected in higher numbers of cells (4610 6 ) (Arrick et al., 1992) . We thus chose the 293 cell line as a model for investigation of tumorigenicity induced by Asp 816 mutant c-Kit. Wild type c-Kit has been shown to transform NIH3T3 cells in the presence of SCF stimulation P-labeled SIEm67 probe. Some samples were preincubated with antibodies against FLAG or STAT3, followed by EMSA analysis. Cytosolic extract from a clone (kit-DH2) expressing D816H mutant c-Kit is included as a control. (c) 293 cells stably transfected with various plasmid constructs as indicated were seeded onto 12-well plates (50 cells/well) and cultured in soft agar media for 14 days before the colonies were counted. A clone (kit-DH2) expressing D816H mutant c-Kit is included as a positive control (Alexander et al., 1991; Caruana et al., 1998) . Caruana et al. (1998 Caruana et al. ( , 1999 also demonstrated a notable ligandindependent transformation of NIH3T3 cells that expressed relatively high levels of wild type c-Kit, particular with its GNNK 7 isoform. By transfecting 293 cells with the GNNK 7 isoform of both wild type and D816H mutant c-kit cDNAs, we show that mutant c-kit-transfected cells have consistently lower levels of c-Kit expression compared with that observed from wild type c-kit-transfected cells, most likely due to the dierential rate of the receptor degradation among these cells . However, despite lower receptor expression, mutant c-kit transfected 293 cells have signi®cantly greater anchorage-independent growth in vitro and form markedly larger tumors in NOD/SCID mice compared with cells transfected with wild type c-kit. These results demonstrate the potent ability of Asp 816 mutant c-Kit to transform nonhematopoietic cells. Such a model system should be very useful for mechanistic studies on how mutant cKit induces tumorigenicity.
Multiple signal transduction pathways can be activated by SCF/c-Kit interaction, including phosphatidylinositol-3-kinase, Ras-Raf-MAP kinase and STAT pathways (Linnekin, 1999) . However, the changes of signal transduction pathways induced by Asp 816 mutant c-Kit that are responsible for mutant c-Kit mediated biological eects are not well understood. Our previous studies have shown that STAT3 and its downstream targets, Bcl-x L and c-myc, are activated by Asp 816 mutant c-Kit in leukemia cells, and that blockade of STAT3 activation by the dominant negative molecule inhibits cytokine-independent survival in these cells (Ning et al., 2001b) It is of interest to note that although DNA binding activity of constitutively activated STAT3 in STAT3-Ctransfected cells is greater than the activity of natural STAT3 homodimers in D816H mutant c-kit-transfected cells, STAT3-C-transfected cells produced about two-thirds the colony numbers of anchorage-independent growth and tumor size in NOD/SCID compared to D816H mutant c-kit-transfected cells. One of the explanations could be that other signal transduction pathways may be also activated by mutant c-Kit, which contribute, together with activated STAT3, to mutant c-Kit induced tumorigenicity. To support this, we have shown that D816H mutant c-Kit constitutively activate PI-3K/Akt pathway in leukemia cells (Ning et al., 2001b) .
Activation of STAT3 has also been implicated in the transforming ability mediated by other tyrosine kinases (Bromberg et al., 1998; Tsai et al., 2000; Turkson et al., 1998; Zong et al., 1998) , although the precise role of STAT3 activation in cell transformation remains a challenging question. STAT3 has been shown to inhibit apoptosis and promote proliferation by regulating the expression of apoptosis suppressors, such as Bcl-x L (Bromberg et al., 1999; Catlett-Falcone et al., 1999) and cell cycle modulators, such as c-myc (Bromberg et al., 1999; Kiuchi et al., 1999) and cyclins (Bromberg et al., 1999; Fukada et al., 1998) . We observed that the inhibition of mutant c-Kit mediated STAT3 activation in 293 cells did not impair cell viability or suppress cell proliferation when the cells were cultured directly on plastic tissue dishes. These results are consistent with the observations that the blockade of STAT3 activation in NIH3T3 cells induced by oncogene products vsrc or ros has no eect on cell viability (Bromberg et al., 1998) and very little eect on cell proliferation (Zong et al., 1998) (Wooten et al., 2000) .
The results that we have presented demonstrate a mechanism by which Asp 816 mutant c-Kit activates STAT3, and, thereby, contributes to tumorigenesis. Activating mutations of cytokine receptors have been implicated in the pathogenesis of a variety of dierent cancers Beghini et al., 2000; Hirota et al., 1998; Hunter and Avalos, 2000; Jeers et al., 1997; Tian et al., 1999; Yokota et al., 1997) . The characterization of altered signal transduction pathways and the resulting functional consequences by mutant receptors should provide essential information for the molecular identi®cation of subsets of malignant diseases as well as for the development of nongenotoxic therapies designed to speci®cally block the abnormal activation of signaling molecules in cancer cells.
Materials and methods

Plasmids and cDNAs
Human wild typc c-kit in GNNK 7 isoform (Crosier et al., 1993) and D816H mutant c-kit cDNAs were cloned into a mammalian expression vector, pcDNA3.1/Neo (Invitrogen, Carlsbad, CA, USA), as described previously (Ning et al., 2001a,b) . Wild type STAT3 cDNA (Pietra et al., 1998) tagged with a FLAG epitope and STAT1 cDNA (Schindler et al., 1992) were cloned into pcDNA3.1/Hygro(+) (Invitrogen). cDNAs for dominant negative STAT3 (Phe substitution at Tyr705, STAT3-YF) (Nakajima et al., 1996) , constitutively activated STAT3 (Cys substitutions at Ala662 and Asn664, STAT3-C) (Bromberg et al., 1999) and dominant negative STAT1 (Phe substitution at Tyr701, STAT1-YF) (Nakajima et al., 1996) were made by PCR mediated mutagenesis and cloned into pcDNA3.1/Hygro(+). Veri®cation of correct sequences was made by sequencing of the cDNA inserts in various constructs.
Cell culture and gene transfection
Reagents for cell culture were purchased from GIBCO ± BRL (Grand Island, NY, USA). Recombinant human SCF (rhSCF) was purchased from PeproTech Inc. (Princeton, NJ, USA). The human embryonic kidney cell line, 293, was obtained from the American Type Culture Collection and maintained in DMEM media containing 10% FCS and antibiotics. Plasmid cDNAs were transfected into 293 cells by DOSPER reagents (Roche Molecular Biochemicals, Indianapolis, IN, USA) following the manufacturer's instructions. Stable lines of cells transfected with dierent constructs were obtained by selection with either G418 or hygromycin as stated in the text.
Western blot and flow cytometry analysis
Total cellular lysates were prepared from cells lysed with modi®ed RIPA2 buer (20 nM Tris/pH 7.4, 137 mM NaCl, 10% glycerol, 0.1% SDS, 1% Triton X-100, 2 mM EDTA and 1 mM DTT), supplemented with protease inhibitors (Roche Molecular Biochemicals). Lysates were centrifuged at 13 000 g at 48C for 20 min to pellet cellular debris and the supernatants were collected. 
Electrophoretic mobility-shift assay (EMSA)
Preparation of cytosolic extracts and EMSA analysis were carried out essentially as described previously (Ning et al., 2001b) . 293 cells (5610 6 ), transfected with dierent constructs, were trypsinized and resuspended in 100 ml of hypotonic buer (20 mM HEPES/pH 7.9, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 0.2% NP-40) with protease inhibitors. After incubation on ice for 15 min, cells were lysed by passage through a 28.5-gauge needle. Debris was removed by a brief centrifugation at 13 000 g. Supernatant was recovered and added with NaCl to a ®nal concentration of 0.1 M. After centrifugation at 13 000 g for 30 min, the resulting fractions (cytosolic extracts) were added with glycerol to 10% and used for EMSA. Radiolabeled highanity SIEm67 (Wagner et al., 1990) probe that was obtained by incubating Klenow enzyme (High Prime, Roche Molecular Biochemicals) and a-[ 32 P]dCTP (NEN) with the annealed oligonucleotides 5'-GTCGACATTTCCCGTAA-ATC-3' and 5'-TCGACGATTTACGGGAAATG-3'. Cytosolic extract (20 mg) was incubated with 1 mg of poly (dI-dC)-poly (dI-dC) (Amersham Pharmacia Biotech) in binding buer (50 mM NaCl, 6 mM HEPES, 1 mM EDTA, 1 mM DTT and 6% glycerol) for 20 min on ice before adding 30 000 c.p.m. of radiolabeled probe. For supershift assays, nuclear extracts were preincubated with anti-FLAG antibody (M2, Sigma) for 40 min on ice before radiolabeled probe was added. Protein-DNA complexes were separated by 5% polyacrylamide gel in 0.56TBE buer containing 2.5% glycerol. Gels were dried and subsequently analysed by autoradiography.
Anchorage-independent growth
Assays for anchorage-independent growth were performed essentially as previously described (Freedman and Shin, 1974; MacAuley and Pawson, 1988) . 1.5 ml of 0.5% agar (DIFCO, Detroit, MI, USA) in DMEM medium with 10% SCF was laid at the bottom of each well in 12-well plates (22 mm diameter/well, BD Labware, Franklin Lakes, NJ, USA), followed by overlaying 1.5 ml of 0.3% agar-DMEM-10% FCS containing the stated number of cells. Culture dishes were ®nally overlaid with 1.0 ml of regular DMEM culture medium, which was replaced every 3 days. Fourteen days later colonies that were visually recognizable (consisting of 4100 cells by microscope) were counted both with and without a microscope. In some experiments, rhSCF (20 ng/ ml) was initially mixed with the top layer of agar, and fresh SCF was added every 3 days through changing the regular DMEM medium on top. Results presented in the text were obtained from three independent experiments each done in duplicate.
Proliferation analysis
To evaluate DNA synthesis, cells (5610 4 /200 ml) were placed in 96-well culture plates in triplicate. Forty-eight hours later, 1 mCi of [ 3 H]thymidine (NEN Life Science Products, Boston, MA, USA) was added to each well and incubated for another 4 h. Cells were harvested and the amount of incorporated radioactivity was quantitated with a liquid-scintillation counter (Packard Instrument, Meriden, CT, USA). Results presented in the text were obtained from three independent experiments each done in triplicate.
In vivo tumor formation
Subcon¯uent cultured 293 cells transfected with various cDNAs were collected and washed twice with PBS. Cells were resuspended in PBS at the concentration of 2610 6 /ml. NOD/SCID mice (purchased from Jackson Laboratories, Bar Harbor, ME, USA) were subcutaneously injected on each side of their shoulders with 0.2 ml of cell suspension (4610 5 cells). Mice were sacri®ced 4 weeks after the injection. Subcutaneous tumors were isolated and their sizes were measured in three dimensions.
